期刊文献+

紫杉醇联合5-氟尿嘧啶和顺铂治疗晚期胃癌58例

Paclitaxel Combined with 5-fluorouracil and Cisplatin in the Treatment of 58 Cases with Advanced Gastric Cancer
下载PDF
导出
摘要 [目的]观察紫杉醇联合5-氟尿嘧啶及顺铂(PCF方案)治疗晚期胃癌的临床疗效和毒副反应。[方法]晚期胃癌患者58例,给予紫杉醇(PTX)150mg/m2,静滴3h,d1;5-氟尿嘧啶(5-Fu)500mg/m2,d1~5或750mg/m2,d1~3;顺铂(DDP)15mg/m2,d1~5或30mg/m2,d1~3;21~28d为1个周期。至少2个周期后按RESCIST标准评价疗效和毒副反应。[结果]全组57例可评价疗效,初治组35例,无完全缓解病例,部分缓解15例,稳定17例,进展3例,近期客观有效率42.9%,中位达进展时间(TTP)为6.0个月。复治组22例,无完全缓解病例,部分缓解3例,稳定16例,进展3例,近期客观有效率13.6%,中位TTP为3.2个月。主要毒副反应为骨髓抑制、恶心呕吐和脱发。[结论]PCF方案治疗晚期胃癌近期疗效确切,毒副反应可以耐受,初治患者效果更佳。 [Purpose] To evaluate the efficacy and toxicity of paclitaxel (PTX) combined with 5-fluorouracil (5-Fu) and cisplatin (DDP) regimen (PCF regimen) in patients with advanced gastric cancer. [Methods] Fifty-eight cases with advanced gastric cancer were treated with PCF regimen: 150mg/m^2 3h d1, 5-Fu 500mg/m^2 d1-5 or 750mg/m^2 d1-3, DDP 15mg/m^2 d1-5 or 30mg/m^2 d1-3 every 21-28 days. Response and toxicity were evaluated according to RESCIST standard after 2 courses. [Results] Fifty-seven cases were available for response evaluation. In the initial treatment group the response rate was 42.9% with CR, 0; PR,15; SD,17;PD,3; and the time to tumor progression (TTP) was 6.0 months.In the retreatment group the response rate was 13.6% with CR,0; PR,3; SD,16; PD,3; and the TTP was 3.2 months. The main toxicities were bone marrow suppression, nausea /vomiting and alopecia. [Conelusion]PCF regimen has an assured response for advanced gastric cancer with tolerable toxicity, especiallv for initial treatment.
机构地区 浙江省肿瘤医院
出处 《肿瘤学杂志》 CAS 2006年第3期217-219,共3页 Journal of Chinese Oncology
关键词 胃肿瘤 紫杉醇 氟尿嘧啶 顺铂 药物疗法 stomach neoplasms paclitaxel fluorouracil cisplatin drug therapy
  • 相关文献

参考文献9

  • 1Wagner AD,Grothe W,Behl S, et al. Chemotherapy for advanced gastric cancer [J]. Cochrane Database Syst Rev,2005, 18(2):4-64.
  • 2Kishimoto T, Imamura H, Furukawa H,et al. Chemotherapy for patients with advanced/recurrent gastric cancer and the practice at our institute [J]. Gan To Kagaku Ryoho,2005, 32(11):1682-1684.
  • 3Ajani JA, Fairweather J, Dumas P, et al. Phase Ⅱ study of Taxol in patients with advanced gastric carcinoma [J].Cancer J Sci Am, 1998, 4(4):269-274.
  • 4Yamaguchi K, Tada M, Horikoshi N, et al. Phase Ⅱ study of paclitaxel with 3-h infusion in patients with advanced gastric cancer[J]. Gastric Cancer, 2002,5(2):90-95.
  • 5Honecker F,Kollmannsberger C, Quietzsch D, et al. Phase Ⅱ study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer [J].Anticancer Drugs, 2002, 13(5):497-503.
  • 6金懋林.胃癌内科化学治疗的新进展[J].医学临床研究,2003,20(10):735-738. 被引量:68
  • 7Lee KW, Im SA, Yun T, et al. Phase Ⅱ trial of low-dose paelitaxel and cisplatin in patients with advanced gastric cancer[J].Jpn J Clin Oncol, 2005, 35(12):720-726.
  • 8Yeh KH, Lu YS, Hsu CH, et al. Phase Ⅱ study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer[J]. Ontology, 2005,69(1):88-95.
  • 9朱蔚友,金时代,束永前,卢凯华,黄普文,刘平,巴一.紫杉醇联合氟尿嘧啶和顺铂方案治疗晚期胃癌[J].临床肿瘤学杂志,2005,10(5):489-491. 被引量:10

二级参考文献18

  • 1卢凯华,黄普文,张锦英,仇金荣,刘连科,朱陵君.乐沙锭联合亚叶酸钙及氟脲嘧啶治疗晚期胃癌22例报告[J].南京医科大学学报(自然科学版),2004,24(5):517-518. 被引量:4
  • 2Sasaki T, Maeda Y, Kobayashi T, et al. Standard chemotherapy for gastrointestinal malignancies based on evidence[J]. Jap J Cancer Chemother , 2000,27(20):166-176.
  • 3Findlay M, Cunningham D, Norman A, et al . A phase Ⅱ study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)[J]. Ann Oncol ,1994,5:609-616.
  • 4Cocconi G. Fluorouracil, doxorubicin,and mitomycin combination versus PELF chemotherapy in advanced gastric cancer:a prospective randomized trial of the Italian Oncology Group for Clinical Research[J]. J Clin Oncol ,1994,21(12) :2687.
  • 5Kim YH, Shin SW, Kim BS, et al . Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma[J]. Cancer , 1999,85:295-301.
  • 6Ajani J. Clinical update on an international phase Ⅱ/Ⅲ docetaxel trial(TAX 325)[J]. Proc Update Meeting on GIC ,2002.
  • 7Kim T, Ahn J,Lee J,et al . A phase Ⅱ trial of capecitabine( X )and cisplantin(P)in previously untreated advanced gastric cancer(AGC)[J]. Proc Am Soc Clin Oncol , 2001,20 : 166.
  • 8金懋林.抗癌新药治疗胃癌进展[A]..抗癌药物与肿瘤化学治疗进展[C].北京:科学出版社,2001.55—64.
  • 9Kim YH,Shin SW,Kim BS,et al.Paclitaxel,5-fluorouracil,and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma[J].Cancer,1999,85(2):295-301.
  • 10Sasaki T,Maeda Y,Kobayashi T,et al.Standard chemotherapy for gastrointestinal malignancies based on evidence[J].Jap J Cancer Chemother,2000,27(20):166-176.

共引文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部